BCG for Therapeutic Use Phase I Clinical Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

April 30, 2025

Conditions
Non-muscular Invasive Bladder Cancer
Interventions
DRUG

BCG for therapeutic use

The 10 patients were infused with BCG 120mg dissolved in 40 \~ 50 mL normal saline once a week for 6 times, then once every 2 weeks for 3 times, and then once a month (30 days) for 10 times, with a total of 19 times.

Trial Locations (1)

Unknown

Hunan Cancer Hospital, Changsha

All Listed Sponsors
lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT06100653 - BCG for Therapeutic Use Phase I Clinical Trial | Biotech Hunter | Biotech Hunter